Share on LinkedInShare on LinkedIn

ARTICLE · 01 FEBRUARY 2022

Pharmaceutical Trademark And Its Conflict With Trademark Law

Khurana & Khurana, Advocates and IP Attorneys
Explore more from Khurana & Khurana, Advocates and IP Attorneys

Out of the many trademarks registered every year, the Indian pharmaceutical industry accounts for a major portion compared to the other sectors.

IndiaIntellectual Property

Out of the many trademarks registered every year, the Indian pharmaceutical industry accounts for a major portion compared to the other sectors. The nature of the relationship between consumers and pharmaceutical companies demands that trademarks assigned to this industry conform to a strict standard of assessing similarity. Herein, the author attempts to demonstrate how the rule of trademark law i.e., the 'Anti-Dissection' rule conflicts with one of the similarity tests of trademark law i.e., the 'Dominant mark' test. By shedding light on the two contradictory concepts in trademark law, it is necessary to consider whether the Court's approach in assessing deceptive similarity helps to maintain the standard in adopting pharmaceutical trademarks.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from